Vontier Reports First Quarter Results and Reaffirms Full Year 2026 Guidance
Go back to Vontier Reports First Quarter Results and Reaffirms Full Year 2026 Guidance| Savient Pharmaceuticals, Inc. (NYSE: VNT) | Delayed: 30.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.19 | 52 Week High | $9.92 | |||
| Open | $30.19 | 52 Week Low | $9.10 | |||
| Day High | $30.19 | P/E | N/A | |||
| Day Low | $30.19 | EPS | $-0.94 | |||
| Volume | 6 | |||||
